Literature DB >> 19931352

MicroRNAs in cancer - from research to therapy.

William C S Cho1.   

Abstract

MicroRNAs (miRNAs) regulate target gene expression through translation repression or mRNA degradation. These non-coding RNAs are emerging as important modulators in cellular pathways, and they appear to play a key role in tumorigenesis. With increasing understanding of the miRNA target genes and the cellular behaviors influenced by them, modulating the miRNA activities may provide exciting opportunities for cancer therapy. Here the latest findings of which genes are targeted by each miRNA are reviewed, with particular emphasis on the deciphering of their possible mechanisms and the potential of miRNA-based cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931352     DOI: 10.1016/j.bbcan.2009.11.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  85 in total

1.  Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.

Authors:  Seyed H Ghaffari; Davood Bashash; Majid Zaki Dizaji; Ardeshir Ghavamzadeh; Kamran Alimoghaddam
Journal:  Tumour Biol       Date:  2011-11-10

2.  A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck.

Authors:  Zhensheng Liu; Sheng Wei; Hongxia Ma; Mei Zhao; Jeffrey N Myers; Randal S Weber; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2011-09-20       Impact factor: 4.944

3.  Competing endogenous RNA: A novel posttranscriptional regulatory dimension associated with the progression of cancer.

Authors:  Qingsong Dai; Jixia Li; Keyuan Zhou; Tong Liang
Journal:  Oncol Lett       Date:  2015-09-14       Impact factor: 2.967

4.  The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.

Authors:  Xiaobing Wu; Shuling Li; Xuehu Xu; Shangbiao Wu; Rong Chen; Qingping Jiang; Yong Li; Yuandong Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

5.  The 'real world' utility of miRNA patents: lessons learned from expressed sequence tags.

Authors:  Bonnie W McLeod; Mark L Hayman; Angela L Purcell; Joshua S Marcus; Erich Veitenheimer
Journal:  Nat Biotechnol       Date:  2011-02       Impact factor: 54.908

6.  Can the chemotherapeutic agents perform anticancer activity through miRNA expression regulation? Proposing a new hypothesis [corrected].

Authors:  Chiranjib Chakraborty; C George Priya Doss; Renu Sarin; Minna J Hsu; Govindasamy Agoramoorthy
Journal:  Protoplasma       Date:  2015-02-20       Impact factor: 3.356

7.  miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1.

Authors:  Gang Peng; Yiwei Liao; Chenfu Shen
Journal:  Pathol Oncol Res       Date:  2016-09-23       Impact factor: 3.201

8.  MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC).

Authors:  Jiali Zhang; Yu Wang; Xinming Chen; Yi Zhou; Fangyan Jiang; Jirong Chen; Li Wang; Wen-Feng Zhang
Journal:  Oncotarget       Date:  2015-04-10

9.  A G-quadruplex DNA-based, label-free and ultrasensitive strategy for microRNA detection.

Authors:  Li Yan; Yiyong Yan; Lei Pei; Wei Wei; Jing Zhao
Journal:  Sci Rep       Date:  2014-12-10       Impact factor: 4.379

10.  miR-197-3p reduces epithelial-mesenchymal transition by targeting ABCA7 in ovarian cancer cells.

Authors:  Weiquan Xie; Chengyu Shui; Xiping Fang; Yuqiu Peng; Li Qin
Journal:  3 Biotech       Date:  2020-08-04       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.